Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up.
OBJECTIVE To determine whether glycemic benefits of the MiniMed 780G Advanced Hybrid Closed-Loop (AHCL) system are sustained over two years in youth with type 1 diabetes (T1D), and to identify outcome predictors. METHODS This prospective multicenter study collected CGM and clinical data at 1,3,6,12, and 24 months in...